Additional file 5 of DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy
Recently, immune response modulation at the epigenetic level is illustrated in studies, but the possible function of RNA 5-methylcytosine (m5C) modification in cell infiltration within the tumor micro
Aberrant DNA hydroxymethylation (5hmC) has been reported in patients with myelodysplastic syndromes (MDS). The dysregulation of 5hmC is not only observed in patients with TET2 mutations, but also thos
Supplementary Table 18. Results from cell type proportion adjusted epigenome wide association study with CellDMC comparing embryonal tumors to non-tumor brain tissue.
Chronic lymphocytic leukemia (CLL) is a genetically, epigenetically, and clinically heterogeneous disease. Despite this heterogeneity, the Bruton tyrosine kinase (BTK) inhibitor ibrutinib provides eff